2,771
Views
24
CrossRef citations to date
0
Altmetric
Research Article

The Effect of Concentrated Growth Factors in the Treatment of Periodontal Intrabony Defects

, , , &
Article: FSO136 | Accepted 13 May 2016, Published online: 15 Sep 2016

References

  • Cortellini P, Tonetti MS. Long-term tooth survival following regenerative treatment of intrabony defects. J. Periodontol. 75(5), 672–678 (2004).
  • Sculean A, Pietruska M, Schwarz F et al. Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study. J. Clin. Periodontol. 32(1), 111–117 (2005).
  • Artzi Z, Tal H, Platner O et al. Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1 year retrospective study. J. Clin. Periodontol. 42(6), 547–456 (2015).
  • Tonetti MS, Cortellini P, Lang NP et al. Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial. J. Clin. Periodontol. 31(9), 770–776 (2004).
  • Sanz M, Tonetti MS, Zabalegui I et al. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial. J. Periodontol. 75(5), 726–733 (2004).
  • MacNeil RL, Somerman MJ. Development and regeneration of the periodontium: parallels and contrasts. Periodontol. 2000 19, 8–20 (1999).
  • Kornman KS, Robertson PB. Fundamental principles affecting the outcomes of therapy for osseous lesions. Periodontol. 2000 22, 22–43 (2000).
  • Sculean A, Windisch P, Keglevich T et al. Clinical and histologic evaluation of humanintrabony defects treated with an enamel matrix proteinderivative combined with a bovine-derived xenograft. Int. J. Periodontics Restorative Dent. 23(1), 47–55 (2003).
  • Susin C, Fiorini T, Lee J et al. Wound healing following surgical and regenerative periodontal therapy. Periodontol. 2000 68, 83–98 (2015).
  • Lynch SE, Williams RC, Polson AM et al. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J. Clin. Periodontol. 16(8), 545–548 (1989).
  • Giannobile WV, Finkelman RD, Lynch SE. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J. Periodontol. 65(12), 1158–1168 (1994).
  • Borzini P, Mazzucco L. Platelet gels and releasates. Curr. Opin. Hematol. 12(6), 473–479 (2005).
  • Whitman DH, Berry RL, Green DM. Platelet gel: anautologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J. Oral Maxillofac. Surg. 55(11), 1294–1299 (1997).
  • Marx RE, Carlson ER, Eichstaedt RM et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 85(6), 638–646 (1998).
  • de Obarrio JJ, Araúz-Dutari JI, Chamberlain TM et al. The use of autologous growth factors in periodontalsurgical therapy: platelet gel biotechnology – case reports. Int. J. Periodontics Restorative. Dent. 20(5), 486–497 (2000).
  • Lekovic V, Camargo PM, Weinlaender M et al. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J. Periodontol. 73(2), 198–205 (2002).
  • Hanna R, Trejo PM, Weltman RL. Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet-rich plasma: a randomized clinical trial. J. Periodontol. 75(12), 1668–1677 (2004).
  • Camargo PM, Lekovic V, Weinlaender M et al. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans. Int. J. Periodontics Restorative. Dent. 25(1), 49–59 (2005).
  • Döri F, Arweiler N, Húszár T et al. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral. J. Periodontol. 84(11), 1546–1555 (2013).
  • Pinipe J, Mandalapu NB, Manchala SR et al. Comparative evaluation of clinical efficacy of β-tri calcium phosphate (Septodont-RTR)™ alone and in combination with platelet rich plasma for treatment of intrabony defects in chronic periodontitis. J. Indian Soc. Periodontol. 18(3), 346–351 (2014).
  • Dohan DM, Choukroun J, Diss A et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101(3), e37–e44 (2006).
  • Dohan DM, Choukroun J, Diss A et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101(3), e45–e50 (2006).
  • Dohan DM, Choukroun J, Diss A et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101, e51–e55 (2006).
  • Choukroun J, Diss A, Simonpieri A et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101(3), e56–e60 (2006).
  • Choukroun J, Diss A, Simonpieri A et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101(3), 299–303 (2006).
  • Rodella LF, Favero G, Boninsegna R et al. Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction. Microsc. Res. Tech. 74(8), 772–777 (2011).
  • Sohn DS, Heo JU, Kwak DH et al. Bone regeneration in the maxillary sinus using an autologous fibrin-rich block with concentrated growth factors alone. Implant Dent. 20(5), 389–395 (2011).
  • Löe H. The gingival index, the plaque index and the retention index systems. J. Periodontol. 38(6), 610–616 (1967).
  • Mazza JE, Newman MG, Sims TN. Clinical and antimicrobial effect of stannous fluoride on periodontitis. J. Clin. Periodontol. 8(3), 203–212 (1981).
  • Yu B, Wang Z. Effect of concentrated growth factors on beagle periodontal ligament stem cells in vitro. Mol. Med. Rep. 9(1), 235–242 (2014).
  • Parimala M, Mehta DS. Comparative evaluation of bovine porous bone mineral. J. Indian Soc. Periodontol. 14(2), 126–131 (2010).
  • Howell TH, Fiorellini JP, Paquette DW et al. A Phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J. Periodontol. 68(12), 1186–1193 (1997).
  • Gassling VL, Açil Y, Springer IN et al. Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 108(1), 48–55 (2009).
  • Matic M, Petrov IN, Chen S et al. Stem cells of the corneal epithelium lack connexins and metabolite transfer capacity. Differentiation 61(4), 251–260 (1997).
  • Ademokun JA, Chapman C, Dunn J et al. Umbilical cord blood collection and separation for haematopoietic progenitor cell banking. Bone Marrow Transplant. 19(10), 1023–1028 (1997).
  • Kikuchi-Taura A, Soma T, Matsuyama T et al. A new protocol for quantifying CD34(+) cells in peripheral blood of patients with cardiovascular disease. Tex. Heart Inst. J. 33(4), 427–429 (2006).
  • Hiatt WH, Stallard RE, Butler ED et al. Repair following mucoperiosteal flap surgery with full gingival retention. J. Periodontol. 39(1), 11–16 (1968).
  • Polson AM, Proye MP. Fibrin linkage: a precursor for new attachment. J. Periodontol. 54(3), 141–147 (1983).